Guardant Health (GH) Change in Receivables (2017 - 2026)

Guardant Health has disclosed Change in Receivables across 10 years of filings, most recently posting $6.9 million for Q2 2026.

• In Q2 2026, Change in Receivables fell 51.88% year-over-year to $6.9 million; the TTM figure through Jun 2026 stood at $13.7 million (down 54.47% YoY), while the FY2025 annual figure was $28.2 million, up 31.73% from the prior year.
• Change in Receivables came in at $6.9 million for Q2 2026 at Guardant Health, up from -$942000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $22.2 million in Q4 2025 to a low of -$14.5 million in Q3 2025.
• Average Change in Receivables over 5 years is $2.6 million, with a median of $2.0 million recorded in 2023.
• The largest YoY upside for Change in Receivables was 120683.33% in 2024 against a maximum downside of 616.19% in 2024.
• Over 5 years, Change in Receivables stood at $11.1 million in 2022, then slumped by 100.16% to -$18000.0 in 2023, then surged by 120683.33% to $21.7 million in 2024, then grew by 2.3% to $22.2 million in 2025, then tumbled by 68.99% to $6.9 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $6.9 million in Q2 2026, -$942000.0 in Q1 2026, and $22.2 million in Q4 2025.